A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
Clinical trial NCT02891226 · COMPLETED
Trial details
- NCT number
- NCT02891226
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-14
- Primary completion
- 2018-12-11
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.